证券时报·数据宝统计，截至今日上午10:30，上证综指3959.58点，收于年线之上，涨跌幅为-0.31%，A 股总成交额为9486.02亿元。到目前为止，今日有34只A股价格突破了年线，其中乖离率较大的个股有龙 迅股份、齐心集团、光云科技等，乖离率分别为15.24%、5.45%、5.43%；蓝黛科技、思特威、老板电 器等个股乖离率较小，刚刚站上年线。 11月18日突破年线个股乖离率排名 | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 年线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 688486 | 龙迅股 份 | 20.00 | 14.64 | 69.30 | 79.86 | 15.24 | | 002301 | 齐心集 团 | 10.07 | 8.23 | 7.05 | 7.43 | 5.45 | | 688365 | 光云科 技 | 6.13 | 3.67 | 13.80 | 14.55 | 5.43 | | 301371 | 敷尔佳 ...

Group 1 - The core business of the company is e-commerce SaaS, which includes e-commerce ERP products [1] - The main e-commerce SaaS products offered by the company include Super Store Manager, Express Assistant, KuaiMai ERP, KuaiMai XiaoZhi Customer Service Robot, ShenHui Art Worker Robot, and YiTao Supply Chain [1]

Core Points - The Shanghai Composite Index is at 4008.92 points, above the annual line, with a change of 0.22% [1] - A total trading volume of A-shares reached 894.89 billion yuan today [1] - 39 A-shares have surpassed the annual line, with notable stocks including Hangxin Technology, Liwang Co., and Chuanfa Longmang, showing significant deviation rates [1] Summary by Category Market Performance - The Shanghai Composite Index is currently at 4008.92 points, reflecting a 0.22% increase [1] - The total trading volume for A-shares today is 894.89 billion yuan [1] Stocks Surpassing Annual Line - 39 A-shares have crossed the annual line, with the highest deviation rates recorded for: - Hangxin Technology: 4.59% - Liwang Co.: 3.56% - Chuanfa Longmang: 3.27% [1] - Other stocks with smaller deviation rates include: - Jiuzhou Group - Dali Kaipu - Tiens Wind Power [1] Detailed Stock Data - Notable stocks and their performance: - Hangxin Technology: +4.52%, turnover rate 5.95%, latest price 17.34 yuan, deviation rate 4.59% [1] - Liwang Co.: +5.42%, turnover rate 5.46%, latest price 28.02 yuan, deviation rate 3.56% [1] - Chuanfa Longmang: +3.57%, turnover rate 3.12%, latest price 13.07 yuan, deviation rate 3.27% [1]

Core Insights - Hongyuan Green Energy's trading volume reached 1.542 billion RMB, marking a new high since November 4, 2024 [1] - The latest stock price increased by 7.70%, with a turnover rate of 7.32% [1] - The previous trading day's total transaction volume for the stock was 466 million RMB [1] Company Overview - Hongyuan Green Energy Co., Ltd. was established on September 28, 2002, with a registered capital of 6,790.22202 million RMB [1]

Core Viewpoint - Guangyun Technology's stock has shown a year-to-date increase of 28.74%, despite recent declines in the short term, indicating potential volatility in its market performance [1][2]. Financial Performance - For the period from January to September 2025, Guangyun Technology achieved a revenue of 405 million yuan, representing a year-on-year growth of 14.87%. However, the company reported a net profit attributable to shareholders of -15.03 million yuan, which is a significant increase in losses by 73.03% compared to the previous year [2]. Stock Market Activity - As of October 28, Guangyun Technology's stock price was 14.56 yuan per share, with a market capitalization of 6.2 billion yuan. The stock experienced a trading volume of 39.38 million yuan and a turnover rate of 0.64% [1]. - The company has seen a net inflow of main funds amounting to 828,800 yuan, with large orders accounting for 8.80% of total purchases and 6.70% of total sales [1]. Shareholder Information - As of September 30, 2025, Guangyun Technology had 14,900 shareholders, a decrease of 9.34% from the previous period. The average number of circulating shares per person increased by 10.30% to 28,573 shares [2]. - The company has distributed a total of 70.18 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, new entrants include Hong Kong Central Clearing Limited and Debon Flexible Allocation Mixed A, holding 3.8463 million shares and 3.7866 million shares, respectively [3].

Core Viewpoint - The company has announced adjustments to its fundraising project structure and a delay in project completion, aiming to enhance the efficiency of fund usage while ensuring compliance with relevant regulations [7][10][12]. Financial Data - The company raised a total of RMB 176,999,996.92 through the issuance of 24,824,684 shares at a price of RMB 7.13 per share, with a net amount of RMB 171,862,516.08 after deducting issuance costs [7][8]. Fundraising Project Adjustments - The internal investment structure of the fundraising project has been optimized to better align with the company's operational needs, including an increase in R&D personnel salaries and a decrease in hardware and software investments [10]. - The project completion date has been postponed to December 2026 due to ongoing R&D work and market conditions [10][11]. Compliance and Oversight - The adjustments have been reviewed and approved by the company's board and the audit committee, confirming that they do not harm shareholder interests and comply with regulatory requirements [12][13]. Investor Communication - The company will hold a performance briefing on November 3, 2025, to discuss the third-quarter results and address investor inquiries [14][15][16].

Group 1 - Company reported Q3 performance with revenue of approximately 405 million yuan, a year-on-year increase of 14.87% [1] - The net profit attributable to shareholders was a loss of approximately 15.03 million yuan, with basic earnings per share showing a loss of 0.04 yuan [1] - As of the report date, the company's market capitalization stood at 6.2 billion yuan [2] Group 2 - The Chinese innovative drug sector has seen significant overseas licensing sales reaching 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is experiencing a fundraising slowdown [2]

申万宏源证券承销保荐有限责任公司 关于杭州光云科技股份有限公司 2022 年以简易程序向特定对象发行股票 募投项目内部投资结构调整及募投项目延期的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"、"保 荐机构"）作为杭州光云科技股份有限公司（以下简称"光云科技"、"公司"）以 简易程序向特定对象发行股票的保荐机构，根据《证券发行上市保荐业务管理 办法》《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关 文件的要求，对光云科技2022年以简易程序向特定对象发行股票募投项目内部 投资结构调整及募投项目延期的事项进行了核查，核查情况及核查意见如下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可〔2023〕306 号文核准，公司向特定对 象发行人民币普通股（A股）24,824,684.00股，发行价格为每股人民币7.13元， 募集资金总额为人民币 176,999,996.92 元，扣除发行费用（不含增值税）人民币 5,137,480.84 元，募集资金净额为人民币 171,862,516.08 元 ...

●会议召开时间：2025年11月03日（星期一）上午11:00-12:00 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 证券代码：688365 证券简称：光云科技 公告编号：2025-059 杭州光云科技股份有限公司 关于召开2025年第三季度业绩说明会的公告 ●会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） ●会议召开方式：上证路演中心网络互动 ●投资者可于2025年10月27日(星期一) 至10月31日(星期五)16:00前登录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公 司 邮 箱 gyir@raycloud.com进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 杭州光云科技股份有限公司（以下简称"公司"）已于 2025 年 10 月 25 日 发布公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计划于 ...

证券代码：688365 证券简称：光云科技 公告编号：2025-058 杭州光云科技股份有限公司 关于 2022 年以简易程序向特定对象发行股票 募投项目内部投资结构调整及募投项目延期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州光云科技股份有限公司（以下简称"公司"）于 2025 年 10 月 24 日召开第 四届董事会第二次会议，审议通过了《关于募投项目内部投资结构调整及募投项 目延期的议案》，同意公司在不改变募集资金投向的前提下，调整 2022 年以简 易程序向特定对象发行股票募集资金投资项目（以下称"募投项目"）内部投资 结构，并对募投项目进行延期。保荐机构申万宏源证券承销保荐有限责任公司（以 下简称"申万宏源承销保荐"）对本事项出具了明确的核查意见。该事项无需提 交公司股东会审议。现将相关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可〔2023〕306 号文核准，公司向特定对 象发行人民币普通股（A 股）24,824,684.00 股，发行价格为每股人民币 7.13 元， 募 ...